Amedisys Inc  

(Public, NASDAQ:AMED)   Watch this stock  
Find more results for Linda R. McCoy
0.00 (0.00%)
Apr 24 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 25.91 - 27.19
52 week 12.86 - 31.27
Open 26.90
Vol / Avg. 113,127.00/173,827.00
Mkt cap 903.11M
P/E 70.19
Div/yield     -
EPS 0.38
Shares 33.67M
Beta 1.06
Inst. own 95%
Jun 1, 2015
Amedisys, Inc. Annual Shareholder Meeting (Estimated) Add to calendar
Apr 29, 2015
Q1 2015 Amedisys Inc Earnings Call - 11:00AM EDT - Add to calendar
Apr 29, 2015
Q1 2015 Amedisys Inc Earnings Release - 9:30AM EDT - Add to calendar
Mar 4, 2015
Q4 2014 Amedisys Inc Earnings Call - Webcast
Mar 4, 2015
Q4 2014 Amedisys Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '14) 2014
Net profit margin 3.10% 1.10%
Operating margin 4.93% 2.00%
EBITD margin - 4.61%
Return on average assets 5.54% 1.91%
Return on average equity 9.38% 3.38%
Employees 13,200 -
CDP Score - -


United States - Map
+1-225-2922031 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Amedisys, Inc. (Amedisys) is a health care at home company. The Company delivers personalized home health and hospice care to approximately 360,000 patients each year. It is focused on delivering patient-centered care, whether that is home-based recovery and rehabilitation after an operation or injury, care focused to manage a chronic disease, palliative care for those with a terminal illness, or hospice care at the end of life. The Company owns and operates approximately 367 Medicare-certified home health care centers, 92 Medicare-certified hospice care centers and one hospice inpatient unit. The Company operates in two segments: home health and hospice. Home health segment delivers a range of services in the homes of individuals who may be recovering from an illness, injury or surgical procedure. Hospice segment provides care that is designed to provide comfort and support for those who are facing a terminal illness.

Officers and directors

Paul B. Kusserow President, Chief Executive Officer, Director
Age: 53
Bio & Compensation  - Reuters
Ronald A. LaBorde Vice Chairman of the Board, Chief Financial Officer
Age: 58
Bio & Compensation  - Reuters
Dan McCoy Chief Operating Officer
Bio & Compensation  - Reuters
David R. Bucey Senior Vice President, General Counsel, Corporate Secretary
Age: 56
Bio & Compensation  - Reuters
David L. Kemmerly Senior Vice President - Government Affairs, Interim General
Bio & Compensation  - Reuters
Martin Howard Chief Information Officer
Bio & Compensation  - Reuters
Jeffrey D. Jeter J.D. Chief Compliance Officer
Age: 42
Bio & Compensation  - Reuters
Michael O. Fleming M.D. Chief Medical Officer
Age: 63
Bio & Compensation  - Reuters
Stephen Seim Chief Strategy Officer
Bio & Compensation  - Reuters
Donald A. Washburn Non-Executive Chairman of the Board
Age: 70
Bio & Compensation  - Reuters